vs

Side-by-side financial comparison of Cryoport, Inc. (CYRX) and GREAT SOUTHERN BANCORP, INC. (GSBC). Click either name above to swap in a different company.

GREAT SOUTHERN BANCORP, INC. is the larger business by last-quarter revenue ($56.4M vs $45.5M, roughly 1.2× Cryoport, Inc.). GREAT SOUTHERN BANCORP, INC. runs the higher net margin — 28.9% vs -17.5%, a 46.4% gap on every dollar of revenue. On growth, Cryoport, Inc. posted the faster year-over-year revenue change (9.6% vs -0.2%). GREAT SOUTHERN BANCORP, INC. produced more free cash flow last quarter ($70.1M vs $-4.5M). Over the past eight quarters, Cryoport, Inc.'s revenue compounded faster (10.4% CAGR vs 4.5%).

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

CYRX vs GSBC — Head-to-Head

Bigger by revenue
GSBC
GSBC
1.2× larger
GSBC
$56.4M
$45.5M
CYRX
Growing faster (revenue YoY)
CYRX
CYRX
+9.9% gap
CYRX
9.6%
-0.2%
GSBC
Higher net margin
GSBC
GSBC
46.4% more per $
GSBC
28.9%
-17.5%
CYRX
More free cash flow
GSBC
GSBC
$74.6M more FCF
GSBC
$70.1M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
CYRX
CYRX
Annualised
CYRX
10.4%
4.5%
GSBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CYRX
CYRX
GSBC
GSBC
Revenue
$45.5M
$56.4M
Net Profit
$-8.0M
$16.3M
Gross Margin
47.8%
Operating Margin
-17.0%
34.5%
Net Margin
-17.5%
28.9%
Revenue YoY
9.6%
-0.2%
Net Profit YoY
57.4%
9.1%
EPS (diluted)
$-0.19
$1.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CYRX
CYRX
GSBC
GSBC
Q4 25
$45.5M
$56.4M
Q3 25
$44.2M
$57.8M
Q2 25
$45.5M
$59.2M
Q1 25
$41.0M
$55.9M
Q4 24
$41.5M
$56.5M
Q3 24
$38.3M
$55.0M
Q2 24
$39.7M
$56.7M
Q1 24
$37.3M
$51.6M
Net Profit
CYRX
CYRX
GSBC
GSBC
Q4 25
$-8.0M
$16.3M
Q3 25
$-6.9M
$17.8M
Q2 25
$105.2M
$19.8M
Q1 25
$-12.0M
$17.2M
Q4 24
$-18.7M
$14.9M
Q3 24
$805.0K
$16.5M
Q2 24
$-78.0M
$17.0M
Q1 24
$-18.9M
$13.4M
Gross Margin
CYRX
CYRX
GSBC
GSBC
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
CYRX
CYRX
GSBC
GSBC
Q4 25
-17.0%
34.5%
Q3 25
-22.5%
38.2%
Q2 25
-21.2%
41.0%
Q1 25
-23.1%
38.4%
Q4 24
-30.7%
31.8%
Q3 24
-34.9%
36.6%
Q2 24
-196.5%
36.8%
Q1 24
-46.9%
32.1%
Net Margin
CYRX
CYRX
GSBC
GSBC
Q4 25
-17.5%
28.9%
Q3 25
-15.7%
30.7%
Q2 25
231.4%
33.4%
Q1 25
-29.2%
30.7%
Q4 24
-45.1%
26.4%
Q3 24
2.1%
30.0%
Q2 24
-196.4%
30.0%
Q1 24
-50.7%
26.0%
EPS (diluted)
CYRX
CYRX
GSBC
GSBC
Q4 25
$-0.19
$1.44
Q3 25
$-0.18
$1.56
Q2 25
$2.05
$1.72
Q1 25
$-0.28
$1.47
Q4 24
$-0.42
$1.27
Q3 24
$-0.02
$1.41
Q2 24
$-1.62
$1.45
Q1 24
$-0.43
$1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CYRX
CYRX
GSBC
GSBC
Cash + ST InvestmentsLiquidity on hand
$411.2M
$189.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$502.6M
$636.1M
Total Assets
$765.0M
$5.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CYRX
CYRX
GSBC
GSBC
Q4 25
$411.2M
$189.6M
Q3 25
$421.3M
$196.2M
Q2 25
$426.0M
$245.9M
Q1 25
$244.0M
$217.2M
Q4 24
$250.6M
$195.8M
Q3 24
$259.4M
$208.4M
Q2 24
$414.9M
$186.5M
Q1 24
$438.2M
$171.4M
Stockholders' Equity
CYRX
CYRX
GSBC
GSBC
Q4 25
$502.6M
$636.1M
Q3 25
$513.3M
$632.9M
Q2 25
$519.1M
$622.4M
Q1 25
$398.8M
$613.3M
Q4 24
$401.9M
$599.6M
Q3 24
$418.6M
$612.1M
Q2 24
$400.1M
$568.8M
Q1 24
$472.2M
$565.2M
Total Assets
CYRX
CYRX
GSBC
GSBC
Q4 25
$765.0M
$5.6B
Q3 25
$774.3M
$5.7B
Q2 25
$773.9M
$5.9B
Q1 25
$699.8M
$6.0B
Q4 24
$703.5M
$6.0B
Q3 24
$701.8M
$6.0B
Q2 24
$852.3M
$6.0B
Q1 24
$942.8M
$5.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CYRX
CYRX
GSBC
GSBC
Operating Cash FlowLast quarter
$919.0K
$81.5M
Free Cash FlowOCF − Capex
$-4.5M
$70.1M
FCF MarginFCF / Revenue
-10.0%
124.3%
Capex IntensityCapex / Revenue
12.0%
20.3%
Cash ConversionOCF / Net Profit
5.01×
TTM Free Cash FlowTrailing 4 quarters
$-25.0M
$121.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CYRX
CYRX
GSBC
GSBC
Q4 25
$919.0K
$81.5M
Q3 25
$2.2M
$5.6M
Q2 25
$-7.3M
$39.3M
Q1 25
$-4.3M
$15.0M
Q4 24
$-5.5M
$44.1M
Q3 24
$447.0K
$17.7M
Q2 24
$-8.0M
$43.5M
Q1 24
$-3.3M
$-26.9M
Free Cash Flow
CYRX
CYRX
GSBC
GSBC
Q4 25
$-4.5M
$70.1M
Q3 25
$-1.3M
$3.9M
Q2 25
$-11.7M
$34.9M
Q1 25
$-7.5M
$13.1M
Q4 24
$-10.7M
$39.1M
Q3 24
$-3.8M
$16.5M
Q2 24
$-11.8M
$42.0M
Q1 24
$-7.3M
$-27.7M
FCF Margin
CYRX
CYRX
GSBC
GSBC
Q4 25
-10.0%
124.3%
Q3 25
-2.9%
6.7%
Q2 25
-25.7%
59.0%
Q1 25
-18.3%
23.4%
Q4 24
-25.8%
69.3%
Q3 24
-9.9%
30.1%
Q2 24
-29.8%
74.1%
Q1 24
-19.5%
-53.7%
Capex Intensity
CYRX
CYRX
GSBC
GSBC
Q4 25
12.0%
20.3%
Q3 25
7.8%
3.0%
Q2 25
9.6%
7.4%
Q1 25
7.7%
3.5%
Q4 24
12.6%
8.7%
Q3 24
11.1%
2.1%
Q2 24
9.5%
2.7%
Q1 24
10.7%
1.6%
Cash Conversion
CYRX
CYRX
GSBC
GSBC
Q4 25
5.01×
Q3 25
0.31×
Q2 25
-0.07×
1.99×
Q1 25
0.87×
Q4 24
2.95×
Q3 24
0.56×
1.07×
Q2 24
2.56×
Q1 24
-2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons